On October 8, 2024, Maven Clinic, a NYC-based virtual clinic for women’s and family health, announced it has raised $125 million in a Series F funding round. The round, which brought the total funding to more than $425 million, was led by StepStone Group, with participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. Wilson Sonsini Goodrich & Rosati represented Maven in the transaction.

The company intends to use the funds to enhance its partnerships in maternity care, invest in its fertility benefits administration platform, and bolster its value-based offering across both fully-insured and Medicaid populations.

Led by CEO and Founder Kate Ryder, Maven is a virtual clinic for women and families. Its digital programs provide clinical, emotional, and financial support all in one platform, spanning fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause and midlife.

More than 2,000 employers and health plans use Maven’s end-to-end platform to improve clinical outcomes, reduce healthcare costs, and provide equity in benefits programs.

The Wilson Sonsini team representing Maven in this transaction is led by Megan Baier, Abi Riddle, and Amy Lucas. 

For more information, please see Maven’s announcement and coverage in Axios Pro, CNBC, and Reuters.